New Research in Treating Leukemia and Lymphoma: ASH Annual Meeting 2020
In this podcast, Dr. Michael Williams discusses studies and a report on the treatment of leukemia and lymphoma presented at last month’s ASH Annual Meeting.
In this podcast, Dr. Michael Williams discusses studies and a report on the treatment of leukemia and lymphoma presented at last month’s ASH Annual Meeting.
Dr. Neeraj Agarwal discusses 3 clinical trials presented at the 2020 ESMO Virtual Congress that studied new treatments for advanced kidney cancer, prostate cancer, and bladder cancer.
Research from the 2020 Quality Care Symposium underscores the effect the COVID-19 pandemic has on Black and Hispanic people with cancer.
In this podcast, Cancer.Net Associate Editors discuss new and emerging research in primary and secondary brain tumors and several types of lymphoma presented at the ASCO20 Virtual Scientific Program.
In this podcast, Cancer.Net Associate Editors discuss new and emerging research in head and neck cancer and melanoma presented at the ASCO20 Virtual Scientific Program.
In this podcast, Cancer.Net Associate Editors discuss new research from the ASCO20 Virtual Scientific Program and what it means for patients.
In this podcast, Cancer.Net Associate Editors share exciting research from the ASCO20 Virtual Scientific Program.
Read research highlights just released from the ASCO20 Virtual Scientific Program. They include studies on immunotherapy for metastatic colorectal cancer and gestational trophoblastic disease, maintenance therapy for advanced bladder cancer, the potential of precision medicine for childhood cancers, and targeted therapy after surgery for EGFR-positive non-small cell lung cancer.
Lea los puntos destacados de la investigación del programa científico virtual ASCO20 que se acaban de publicar. Incluyen estudios sobre inmunoterapia para el cáncer colorrectal metastásico y la enfermedad trofoblástica gestacional, terapia de mantenimiento para el cáncer de vejiga avanzado, el potencial de la medicina de precisión para el cáncer infantil y la terapia dirigida después de la cirugía por EGFR (receptor del factor de crecimiento epidérmico), positivo de cáncer de pulmón de células no pequeñas.
El programa científico virtual ASCO20 es donde muchos investigadores del cáncer anunciarán sus últimos hallazgos. La investigación de hoy destaca 2 estudios que abordan cómo afecta la pandemia del coronavirus a las personas con cáncer.